News

Adaptive optics reveals undetected microcysts in retinal neurodegeneration

In a study in autosomal-dominant optic atrophy (ADOA), conducted at the University of Copenhagen - Rigshospitalet and the…

Imagine Eyes laureate of NEXT French Healthcare

We are happy to share that Imagine Eyes has been selected for NEXT French Healthcare, an acceleration program dedicated…

ARVO 2022 – New retinal findings with Imagine Eyes’ AO imaging

At ARVO 2022, users of Imagine Eyes’ adaptive optics (AO) imaging systems will present new clinical findings in several retinal diseases, myopia, as well as multiple sclerosis. They will report on cellular phenotypes, structure-function relations, and surgical outcomes assessed at the cellular level.

Replay available: Webinar on microvascular AO imaging

Discussion with 3 clinical experts on AO retinal imaging for diseases that alter small blood vessels.

New technique detects small drusen in AMD

In a joint study in age-related macular degeneration (AMD), clinical researchers at the University of Pittsburgh, USA, and…

Study compares AO and OCT biomarkers of rod-cone dystrophy progression

A longitudinal cohort study in rod-cone dystrophy (RCD) conducted by clinical researchers at the Lions Eye Institute in Perth,…

AO for fighting IRDs – Webinar replay available

30min roundtable discussion with 3 clinical experts on the use of AO retinal imaging in inherited retinal diseases.

H2020 MERLIN project celebrates successful final review

At Imagine Eyes we are happy to announce the successful completion of our Horizon 2020 MERLIN project. We received a very…

i2eye meeting – Innovative Imaging in Eye Disease

Users of Imagine Eyes' adaptive optics retinal imaging systems will present 11 talks about phenotyping and monitoring of diseases in the retina...